2-C-Methylerythritol 4-phosphate
2-C-Methylerythritol 4-phosphate (MEP) is a critical intermediate in the non-mevalonate pathway (also known as the MEP/DOXP pathway) of isoprenoid biosynthesis. This pathway is responsible for the production of essential isoprenoids in most bacteria, algae, and plants, but is absent in animals, making it an interesting target for the development of antibiotics, herbicides, and antimalarial drugs.
Biosynthesis[edit | edit source]
The MEP pathway begins with the condensation of pyruvate and glyceraldehyde 3-phosphate (G3P) to produce 1-deoxy-D-xylulose 5-phosphate (DXP). Through a series of enzymatic reactions, DXP is then converted to 2-C-methylerythritol 4-phosphate. The enzyme IspE catalyzes the conversion of MEP to 4-diphosphocytidyl-2-C-methyl-D-erythritol, a further step in the pathway leading to the production of isoprenoids.
Function[edit | edit source]
Isoprenoids, the products of the MEP pathway, are a large and diverse group of molecules that play crucial roles in various biological processes. They are involved in the synthesis of chlorophylls, carotenoids, plant hormones, and quinones. In bacteria, isoprenoids are essential for the synthesis of cell membrane constituents and electron transport chain components.
Clinical Significance[edit | edit source]
Due to its absence in humans, the MEP pathway is an attractive target for the development of new antimicrobial and antiparasitic agents. Inhibitors of the MEP pathway enzymes have shown potential as antibiotics against a range of bacteria and as antimalarial agents. For example, fosmidomycin, an inhibitor of the enzyme DOXP reductoisomerase (which acts early in the MEP pathway), has shown efficacy against Plasmodium falciparum, the parasite responsible for malaria.
Research[edit | edit source]
Research into the MEP pathway and its inhibitors is ongoing, with the aim of developing new therapeutic agents. Understanding the structure and function of the enzymes involved in the MEP pathway is crucial for the design of effective inhibitors.
See Also[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD